|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sideris M and Papagrigoriadis S: Molecular
biomarkers and classification models in the evaluation of the
prognosis of colorectal cancer. Anticancer Res. 34:2061–2068.
2014.PubMed/NCBI
|
|
3
|
Holubec L, Polivka J Jr, Safanda M, Karas
M and Liska V: The role of cetuximab in the induction of anticancer
immune response in colorectal cancer treatment. Anticancer Res.
36:4421–4426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen BJ, Wu YL, Tanaka Y and Zhang W:
Small molecules targeting c-Myc oncogene: Promising anti-cancer
therapeutics. Int J Biol Sci. 10:1084–1096. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Raskov H, Pommergaard HC, Burcharth J and
Rosenberg J: Colorectal carcinogenesis–update and perspectives.
World J Gastroenterol. 20:18151–18164. 2014. View Article : Google Scholar
|
|
6
|
Tejada-Simon MV: Modulation of actin
dynamics by Rac1 to target cognitive function. J Neurochem.
133:767–779. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fritz G and Henninger C: Rho GTPases:
Novel players in the regulation of the DNA damage response.
Biomolecules. 5:2417–2434. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lawson CD and Burridge K: The on-off
relationship of Rho and Rac during integrin-mediated adhesion and
cell migration. Small GTPases. 5:e279582014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pick E: Role of the Rho GTPase Rac in the
activation of the phagocyte NADPH oxidase: Outsourcing a key task.
Small GTPases. 5:e279522014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marei H and Malliri A: Rac1 in human
diseases: The therapeutic potential of targeting Rac1 signaling
regulatory mechanisms. Small GTPases. Jul 21–2016.Epub ahead of
print. PubMed/NCBI
|
|
11
|
Alonso-Espinaco V, Cuatrecasas M, Alonso
V, Escudero P, Marmol M, Horndler C, Ortego J, Gallego R,
Codony-Servat J, Garcia-Albeniz X, et al: RAC1b overexpression
correlates with poor prognosis in KRAS/BRAF WT metastatic
colorectal cancer patients treated with first-line FOLFOX/XELOX
chemotherapy. Eur J Cancer. 50:1973–1981. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ji J, Feng X, Shi M, Cai Q, Yu Y, Zhu Z
and Zhang J: Rac1 is correlated with aggressiveness and a potential
therapeutic target for gastric cancer. Int J Oncol. 46:1343–1353.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen QY, Xu LQ, Jiao DM, Yao QH, Wang YY,
Hu HZ, Wu YQ, Song J, Yan J and Wu LJ: Silencing of Rac1 modifies
lung cancer cell migration, invasion and actin cytoskeleton
rearrangements and enhances chemosensitivity to antitumor drugs.
Int J Mol Med. 28:769–776. 2011.PubMed/NCBI
|
|
14
|
Hein AL, Post CM, Sheinin YM, Lakshmanan
I, Natarajan A, Enke CA, Batra SK, Ouellette MM and Yan Y: RAC1
GTPase promotes the survival of breast cancer cells in response to
hyper-fractionated radiation treatment. Oncogene. 35:6319–6329.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bid HK, Roberts RD, Manchanda PK and
Houghton PJ: RAC1: An emerging therapeutic option for targeting
cancer angiogenesis and metastasis. Mol Cancer Ther. 12:1925–1934.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lv Z, Hu M, Zhen J, Lin J, Wang Q and Wang
R: Rac1/PAK1 signaling promotes epithelial-mesenchymal transition
of podocytes in vitro via triggering β-catenin transcriptional
activity under high glucose conditions. Int J Biochem Cell Biol.
45:255–264. 2013. View Article : Google Scholar
|
|
17
|
Kallergi G, Agelaki S, Markomanolaki H,
Georgoulias V and Stournaras C: Activation of FAK/PI3K/Rac1
signaling controls actin reorganization and inhibits cell motility
in human cancer cells. Cell Physiol Biochem. 20:977–986. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Myant KB, Cammareri P, McGhee EJ, Ridgway
RA, Huels DJ, Cordero JB, Schwitalla S, Kalna G, Ogg EL, Athineos
D, et al: ROS production and NF-κB activation triggered by RAC1
facilitate WNT-driven intestinal stem cell proliferation and
colorectal cancer initiation. Cell Stem Cell. 12:761–773. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Myant KB, Scopelliti A, Haque S, Vidal M,
Sansom OJ and Cordero JB: Rac1 drives intestinal stem cell
proliferation and regeneration. Cell Cycle. 12:2973–2977. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Espina C, Céspedes MV, García-Cabezas MA,
Gómez del Pulgar MT, Boluda A, Oroz LG, Benitah SA, Cejas P, Nistal
M, Mangues R, et al: A critical role for Rac1 in tumor progression
of human colorectal adenocarcinoma cells. Am J Pathol. 172:156–166.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu C, Zhang S, Song L, Wang Y, Hwaiz R,
Luo L and Thorlacius H: Rac1 signaling regulates
neutrophil-dependent tissue damage in experimental colitis. Eur J
Pharmacol. 741:90–96. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li G, Ying L, Wang H, Wei SS, Chen J, Chen
YH, Xu WP, Jie QQ, Zhou Q, Li YG, et al: Rac1b enhances cell
survival through activation of the JNK2/c-JUN/Cyclin-D1 and
AKT2/MCL1 pathways. Oncotarget. 7:17970–17985. 2016.PubMed/NCBI
|
|
23
|
Huang YS, Xie N, Su Q, Su J, Huang C and
Liao QJ: Diallyl disulfide inhibits the proliferation of HT-29
human colon cancer cells by inducing differentially expressed
genes. Mol Med Rep. 4:553–559. 2011.PubMed/NCBI
|
|
24
|
Zhou Y, Su J, Shi L, Liao Q and Su Q: DADS
downregulates the Rac1/ROCK1/PAK1-LIMK1-ADF/cofilin signaling
pathway, inhibiting cell migration and invasion. Oncol Rep.
29:605–612. 2013. View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(Delta DeltaC(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pohl M and Schmiegel W: Therapeutic
strategies in diseases of the digestive tract - 2015 and beyond
targeted therapies in colon cancer today and tomorrow. Dig Dis.
34:574–579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Zhang J, Li L, Xu X, Zhang Y, Teng
Z and Wu F: Identification of molecular targets for predicting
colon adenocarcinoma. Med Sci Monit. 22:460–468. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoshida T, Zhang Y, Rivera Rosado LA, Chen
J, Khan T, Moon SY and Zhang B: Blockade of Rac1 activity induces
G1 cell cycle arrest or apoptosis in breast cancer cells through
downregulation of cyclin D1, survivin, and X-linked inhibitor of
apoptosis protein. Mol Cancer Ther. 9:1657–1668. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leng R, Liao G, Wang H, Kuang J and Tang
L: Rac1 expression in epithelial ovarian cancer: Effect on cell EMT
and clinical outcome. Med Oncol. 32:3292015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leve F and Morgado-Díaz JA: Rho GTPase
signaling in the development of colorectal cancer. J Cell Biochem.
113:2549–2559. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rathinam R, Berrier A and Alahari SK: Role
of Rho GTPases and their regulators in cancer progression. Front
Biosci (Landmark Ed). 16:2561–2571. 2011. View Article : Google Scholar
|
|
33
|
Champeris Tsaniras S, Kanellakis N,
Symeonidou IE, Nikolopoulou P, Lygerou Z and Taraviras S: Licensing
of DNA replication, cancer, pluripotency and differentiation: An
interlinked world. Semin Cell Dev Biol. 30:174–180. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Orlando DA, Lin CY, Bernard A, Wang JY,
Socolar JE, Iversen ES, Hartemink AJ and Haase SB: Global control
of cell-cycle transcription by coupled CDK and network oscillators.
Nature. 453:944–947. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dang CV and Lewis BC: Role of oncogenic
transcription factor c-Myc in cell cycle regulation, apoptosis and
metabolism. J Biomed Sci. 4:269–278. 1997. View Article : Google Scholar
|
|
37
|
Sipos F, Firneisz G and Műzes G:
Therapeutic aspects of c-MYC signaling in inflammatory and
cancerous colonic diseases. World J Gastroenterol. 22:7938–7950.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Surget S, Khoury MP and Bourdon JC:
Uncovering the role of P53 splice variants in human malignancy: A
clinical perspective. Onco Targets Ther. 7:57–68. 2013.
|
|
39
|
Diehl JA: Cycling to cancer with cyclin
D1. Cancer Biol Ther. 1:226–231. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mohanty S, Mohanty A, Sandoval N, Tran T,
Bedell V, Wu J, Scuto A, Murata-Collins J, Weisenburger DD and Ngo
VN: Cyclin D1 depletion induces DNA damage in mantle cell lymphoma
lines. Leuk Lymphoma. 58:676–688. 2017. View Article : Google Scholar
|
|
41
|
Zhou J, Li LU, Fang LI, Xie H, Yao W, Zhou
X, Xiong Z, Wang LI, Li Z and Luo F: Quercetin reduces cyclin D1
activity and induces G1 phase arrest in HepG2 cells. Oncol Lett.
12:516–522. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Posternak V and Cole MD: Strategically
targeting MYC in cancer. F1000Res. 5:F10002016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rajput S, Khera N, Guo Z, Hoog J, Li S and
Ma CX: Inhibition of cyclin dependent kinase 9 by dinaciclib
suppresses cyclin B1 expression and tumor growth in triple negative
breast cancer. Oncotarget. 7:56864–56875. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Oleinik V, Helke KL, Kistner-Griffin E,
Krupenko I and Krupenko SA: Rho GTPases RhoA and Rac1 mediate
effects of dietary folate on metastatic potential of A549 cancer
cells through the control of cofilin phosphorylation. J Biol Chem.
289:26383–26394. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gastonguay A, Berg T, Hauser AD, Schuld N,
Lorimer E and Williams CL: The role of Rac1 in the regulation of
NF-κB activity, cell proliferation, and cell migration in non-small
cell lung carcinoma. Cancer Biol Ther. 13:647–656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
McMahon SB: MYC and the control of
apoptosis. Cold Spring Harb Perspect Med. 4:a0144072014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nikolova E, Mitev V, Minner F, Deroanne CF
and Poumay Y: The inhibition of the expression of the small Rho
GTPase Rac1 induces differentiation with no effect on cell
proliferation in growing human adult keratinocytes. J Cell Biochem.
103:857–864. 2008. View Article : Google Scholar
|
|
48
|
Kalra N and Kumar V: c-Fos is a mediator
of the c-myc-induced apoptotic signaling in serum-deprived hepatoma
cells via the p38 mitogen-activated protein kinase pathway. J Biol
Chem. 279:25313–25319. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Parri M and Chiarugi P: Rac and Rho
GTPases in cancer cell motility control. Cell Commun Signal.
8:232010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sanz-Moreno V, Gadea G, Ahn J, Paterson H,
Marra P, Pinner S, Sahai E and Marshall CJ: Rac activation and
inactivation control plasticity of tumor cell movement. Cell.
135:510–523. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Vader P, van der Meel R, Symons MH, Fens
MH, Pieters E, Wilschut KJ, Storm G, Jarzabek M, Gallagher WM,
Schiffelers RM, et al: Examining the role of Rac1 in tumor
angiogenesis and growth: A clinically relevant RNAi-mediated
approach. Angiogenesis. 14:457–466. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Brantley-Sieders DM, Zhuang G, Vaught D,
Freeman T, Hwang Y, Hicks D and Chen J: Host deficiency in Vav2/3
guanine nucleotide exchange factors impairs tumor growth, survival,
and angiogenesis in vivo. Mol Cancer Res. 7:615–623. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Westermarck J and Kähäri VM: Regulation of
matrix metalloproteinase expression in tumor invasion. FASEB J.
13:781–792. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jin G, Sah RL, Li YS, Lotz M, Shyy JY and
Chien S: Biomechanical regulation of matrix metalloproteinase-9 in
cultured chondrocytes. J Orthop Res. 18:899–908. 2000. View Article : Google Scholar
|
|
55
|
Yang WH, Lan HY, Huang CH, Tai SK, Tzeng
CH, Kao SY, Wu KJ, Hung MC and Yang MH: RAC1 activation mediates
Twist1-induced cancer cell migration. Nat Cell Biol. 14:366–374.
2012. View Article : Google Scholar : PubMed/NCBI
|
